Glaxosmithkline Plc Reaffirms FY 2013 EPS Guidance-Conference Call


Wednesday, 24 Jul 2013 

Glaxosmithkline Plc announced that for fiscal 2013, it continues to expect core EPS growth of around 3% to 4% and turnover growth of around one 1%, both on a constant currency basis. The Company reported revenue of $42.025 billion and earnings per share (EPS) of $3.53 for fiscal 2012. 

Company Quote

48.37
-0.1 -0.21%
31 Jul 2014